“A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence”, LJMHR, vol. 24, no. 6, pp. 63–87, Jul. 2024, Accessed: Feb. 02, 2026. [Online]. Available: https://journalspress.uk/index.php/LJMHR/article/view/920